As a Radioligand Therapeutics (bioconjugates) ADME Project Leader, bring integrated ADME subject matter expertise, driving holistic ADME strategy by aligning pharmacokinetics, metabolism, and mechanistic disposition data with early safety signals; interpret exposure-toxicity relationships, therapeutic index, and off-target liabilities to proactively de-risk programs and enable data-driven candidate selection decisions. The successful candidate will bring exceptional scientific depth, acumen, and leadership as an integral member of the project team to create bold Target Product Profiles, help establish molecule design strategy, expectations, Research Operating Plans, and partner globally, cross-functionally, and ensure teams are advancing The Right Molecule to The Right Study at The Right Time (our three R's).